Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
Purity | ≥70% |
---|---|
Formula | C16H14N2O4 |
Formula Wt. | 298.29 |
Appearance | Red Powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
Tricyclic benzonaphthyridinone; mTORC1/2 inhibi...
Endogenous peptide hormone; GnRH agonist.
CB1 receptor antagonist/ inverse agonist.
c-MET and Ron inhibitor.
Calcium channel blocker.
Tetrapeptide, binds cell surface integrins.
Trichothecene mycotoxin produced by Fusarium, a...
CRM1-selective inhibitor of nuclear export.
α-glucosidase inhibitor, potential GLP-1 agoni...
Salicylic acid prodrug, NSAID; weak COX-1/2 inh...
PARP inhibitor; potential Pim1 inhibitor.
Glycoprotein IIb/IIIa inhibitor.
HDAC inhibitor, RNA splicing modulator.
TRPV1 agonist, histamine H1 antagonist.
Aromatase inhibitor.
Nucleoside (guanosine) analog; RT, guanylyl cyc...
Endogenous peptide, involved in immune signalin...
Glutathione-sulforaphane conjugate, antioxidant...
Flavone found in Teucrium.
Polymixin, antimicrobial peptide, induces forma...